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Abstract
BACKGROUND: Surgical management of infective endocarditis can be challenging. Veteran patients
are unique because they often have significant comorbidities, and surgical management of endocarditis
in this population has not been well described.
METHODS: Using a prospective database, 46 consecutive patients who underwent valve surgery for
acute infective endocarditis between 1987 and 2009 were identified. Survival was assessed using the
Kaplan-Meier method.
RESULTS: All patients were men (mean age, 56  9 years). The most common indication for
surgical intervention was congestive heart failure (60%). The aortic valve was the only valve infected
in most patients (65%). Operative morbidity and mortality were 33% and 9%, respectively. The 1-year,
3-year, 5-year, and 10-year unadjusted survival rates were 72%, 57%, 51%, and 30%, respectively.
CONCLUSIONS: Although acceptable short-term outcomes can be achieved in veterans undergoing
surgical treatment for endocarditis, unadjusted long-term survival may be poor.
Published by Elsevier Inc.
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Infective endocarditis is an uncommon but life-threaten-
ing disease, with an estimated incidence of 3 to 10 episodes
per 100,000 person-years and mortality of up to 50%.1
Despite improved antibiotic regimens and critical care, the
management of infective endocarditis remains a challenge.
Surgical intervention may be lifesaving, but it is difficult to
determine which patients are most likely to benefit. Indica-
tions for surgery continue to evolve but often include in-
tractable heart failure, embolic events, the presence of in-
fected prosthetic material, and unresolved sepsis.2 Although
operative mortality appears to be improving, it remains
substantial, down from 30% in the past 2 decades to a
reported 12% in more recent studies.3,4
Veterans are a unique patient population, because they
often have significant comorbidities. Surgical management
of endocarditis in this population has not been adequately
described, and findings from surgical studies of other patient
populations may not apply to the veteran population. Be-
cause evaluation of surgical outcomes in the veteran popu-
lation is needed to help direct management and determine
prognoses, we report the indications and outcomes of sur-
gical management of endocarditis in patients at a US De-
partment of Veterans Affairs (VA) facility.
This paper was presented at the annual meeting of the Association of
VA Surgeons, Indianapolis, Indiana, May 9 to 11, 2010.
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Methods
This study was granted waiver of informed consent and
approved by the institutional review boards of the Michael
E. DeBakey VA Medical Center (MEDVAMC) and Baylor
College of Medicine. Data on 46 consecutive patients who
underwent valve surgery for active infective endocarditis
from January 1987 to January 2009 at the MEDVAMC
were analyzed. Data were collected from the MEDVAMC’s
Continuous Improvement in Cardiac Surgery Program da-
tabase and supplemented by a thorough review of the pa-
tients’ medical records. Access to complete medical records
was possible for 32 patients.
The Continuous Improvement in Cardiac Surgery Pro-
gram is a prospective database, organized by the VA, to
provide continuous assessment and improved quality of care
for all patients who undergo cardiac surgery at VA hospitals
and contains comprehensive data on 140 variables, in-
cluding demographic, clinical, outcome, and resource vari-
ables.5–7 The death index component of the database was
obtained from the Beneficiary Identification Records Loca-
tor Subsystem death file, which contains information about
veterans known to have died from any cause.
During all procedures, cardiopulmonary bypass, sys-
temic hypothermia, and cardioplegia for myocardial protec-
tion were used. Intraoperative transesophageal echocardiog-
raphy was performed in all patients for whom complete
records were available. The operative procedure included
debridement of all affected areas, copious irrigation, recon-
struction of any defects, and either valve repair or replace-
ment with a prosthetic valve. Aortic root replacement with
a homograft was preferred in the presence of destructive
aortic root infection or abscess.
Data were analyzed using SAS version 9.1 (SAS Institute
Inc, Cary, NC) to assess unadjusted survival using Kaplan-
Meier methodology.
Results
All 46 patients were men, with a mean age of 56  9
years. The risk profiles of the patients are summarized in
Table 1. Forty-three patients (93%) had native valve endo-
carditis, and 3 (7%) had prosthetic valve endocarditis. The
aortic valve was the only valve infected in 30 of the patients
(65%), and multiple valves were involved in 7 (15%). Aor-
tic root replacement with homografts was performed in 7
patients (15%) and valve repair in 5 (11%).
Information about clinical factors, such as blood culture
results and echocardiographic findings, was obtained from
the medical records in 32 of the patients (70%) (Table 2).
Most patients underwent operations early in their courses of
illness, the vast majority (81%) within 1 week from the time
of surgical consultation. Although many patients had 1
indication for operative intervention, the most common was
congestive heart failure (60% of patients). Evidence of pre-
operative emboli was present in 25% of patients. Trans-
Table 1 Risk profile and preoperative status of veterans
with endocarditis (n  46)
Characteristic Value
Age (y) 56  9
Men 46 (100)
Previous valve surgery 3 (6.5)
Diabetes 7 (15)
Cerebrovascular disease 14 (30)
Active smokers 17 (37)
Chronic obstructive pulmonary disease 16 (35)
Pulmonary rales 38 (83)
New York Heart Association class III
or IV symptoms 35 (76)
Concomitant coronary artery disease 5 (11)
Previous myocardial infarction 11 (24)
Emergency operation 22 (48)
Valves involved
Aortic (isolated) 30 (65)
Mitral (isolated) 8 (17)
Tricuspid (isolated) 1 (2)
Multiple valves 7 (15)
Data are expressed as mean  SD or as number (percentage).
Table 2 Clinical characteristics of veterans with
endocarditis (n  32)
Characteristic n (%)
Organisms by blood culture
Staphylococcus 11 (34)
Streptococcus 6 (19)
Enterococcus 7 (22)
Culture negative 6 (19)
Other 2 (6)
Fever 21 (66)
Elevated white blood cell count 20 (63)
Operative indications
Congestive heart failure 19 (60)
Uncontrolled infection 9 (28)
Cardiogenic or septic shock 5 (16)
Preoperative embolic event 8 (25)
Preoperative echocardiographic findings
Perivalvular abscess 12 (38)
New valve regurgitation on echocardiography 29 (91)
Vegetation on preoperative echocardiography 18 (56)
Time from diagnosis to operation  1 wk 17 (53)
Time from surgical consultation to operation
 1 wk 26 (81)
Source of infection
Intravenous drug abuse 7 (22)
Soft-tissue infection 4 (13)
Pyelonephritis 2 (6)
Dental 2 (6)
Dialysis 1 (3)
Other/unknown 16 (50)
Operative findings
Vegetation 27 (84)
Perivalvular abscess 12 (38)
Valve perforation 15 (47)
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esophageal echocardiography identified valvular abscesses
in 38% of patients and vegetations in 56% of patients
(average size, 9.8 mm). Results of cultures of excised tis-
sues were positive in 47% of patients.
Operative mortality was 9%, and morbidity was 33%.
Postoperative complications are summarized in Table 3.
Recurrent endocarditis occurred in 4 patients (9%), all of
whom were treated medically. Four patients died, 3 of low
cardiac output on the day of surgery and 1 of multiple-organ
failure after 30 days in the intensive care unit. All 4 of these
patients required emergency aortic valve surgery, and 2
were in preoperative cardiogenic or septic shock. In addi-
tion, valvular abscesses necessitating homograft root re-
placement were present in 2 of these 4 patients.
Unadjusted survival was 72% at 1 year (95% confidence
interval [CI], 56%–83%), 57% at 3 years (95% CI, 41%–
70%), 51% at 5 years (95% CI, 35%–65%), and 30% at 10
years (95% CI, 15%–46%) (Fig. 1).
Comments
Our results reflect a tendency in our facility toward early
surgical management, with an acceptably low operative
morbidity and mortality despite a critically ill patient pop-
ulation. A trend toward early mortality risk was noted in
patients with hemodynamic compromise and with advanced
infection requiring more extensive surgery. We believe that
early referral for surgery, before patients have irreversible
end-organ damage from heart failure or sepsis, is important
for minimizing operative morbidity and mortality.
Our short-term results compare favorably with those of
other recent surgical series.3,4 Although age, persistent in-
fection, renal failure, shock, prosthetic endocarditis, and
impaired ventricular function have been identified as pre-
dictors of poor survival,3,4,8,9 our study’s small sample size
precluded us from confirming the importance of these fac-
tors.
Indications for surgery had a similar distribution to those
of other surgical series of active complicated endocardi-
tis.3,4,8 The most common indication for urgent surgical
intervention is usually intractable heart failure, as was the
case for 60% of the patients in our study. Twenty-eight
percent of our patients had uncontrolled infection, another
indication for early surgery. Several of the patients in our
study had multiple indications for surgical intervention,
including embolic events, perivalvular abscess, shock, and
multidrug-resistant organisms.
Although surgical risk may be higher during the acute
phase of endocarditis infection, there are clearly times when
earlier surgical intervention is lifesaving. In fact, early sur-
gery is now thought to be an important determinant of
outcomes in complicated endocarditis, with studies showing
a clinically and statistically significant difference in mortal-
Table 3 Operative morbidity and mortality in veterans
with endocarditis (n  46)
Operative Result n (%)
Operative mortality 4 (9)
Perioperative complications
Reexploration for bleeding 0
Myocardial infarction 0
Stroke 0
Mediastinitis 1 (2)
Heart block 2 (4)
Prolonged ventilation 10 (22)
Renal failure 1 (2)
Recurrent endocarditis 4 (9)
Total patients with complications 15 (33)
Figure 1 Kaplan-Meier survival curve in veterans with endocarditis.
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ity between patients treated medically (32%) and surgically
(20%).10–12
More controversial is the exact role of surgery in pre-
venting embolic events in uncomplicated endocarditis. In
our study, only 1 patient underwent surgery for the sole
indication of a large, mobile vegetation. Although embolic
events are common in infective endocarditis (a reported
20%–50%), they are most often a presenting symptom and
usually occur before antibiotic therapy is initiated. After
antibiotics are started, the risk for new embolic events is 3%
to 21% and mostly within the first week of illness.1,2,13
Theoretically, surgeons could focus on early operation only
for those patients with increased risk for emboli, which
includes Staphylococcus infection, mobile vegetations, mi-
tral valve vegetations, and vegetations  1 cm (highest risk
if vegetations are 1.5 cm).1,2,13,14 However, results from
one study refute the notion that vegetation size is associated
with increased embolic risk,15 and surgical risk may be
higher in the acute phase of illness. Thus, the value of early
surgery for vegetations alone is still questioned.
Periannular extension of infection or abscess, which oc-
curred in 38% of our patients, is common in aortic valve
endocarditis (10%–40%)16 and is predictive of higher mor-
tality.3,17 Two of the 4 early deaths in our study involved
patients with extensive periannular aortic destruction recon-
structed with homograft root replacement. The use of ho-
mografts in the presence of severe tissue destruction has
been shown to help considerably with reconstruction of the
aortic root,18 with a low incidence of sewing-ring infec-
tions.19,20 However, Avierinos et al21 found that conven-
tional prostheses implanted during the active phase of aortic
endocarditis have a similar long-term prognosis as that of
homografts, so the increased surgical time required to place
a homograft may not be worth the risk if there is not
significant root destruction.21
The unadjusted long-term survival for patients in our
study was poor compared with that reported in other studies,
with 10-year survival of 30% in our study versus 52% to
73% in other studies.3,4,8 The difference may be due in part
to the relatively older age of our patients, who had a mean
age of 56  9 years compared with a mean patient age of
about 50 years in other studies, and to the strength of the
database we used in reporting late deaths. However, these
results may also indicate that veterans with serious illnesses
such as endocarditis have an increased long-term mortality
risk, which may be worth taking into consideration when
advising patients. For example, on the basis of this study,
decisions concerning use of bioprosthetic valves in veterans
with active endocarditis should not be dictated by age alone.
Valve deterioration is less likely to become an issue, be-
cause longevity appears to be decreased in this population.
Strengths of our study include its long-term and com-
plete follow-up, a unique patient cohort, and a strong and
complete database. Also, ours is one of the few reports on
the surgical management and outcomes of active endocar-
ditis in veterans; the only other report we could find with
regard to endocarditis in this patient population addressed
only prosthetic valve endocarditis in a multicenter study.22
Finally, the reporting of early and late outcomes can be an
important determinant for risk assessment and surgical de-
cision making.
Limitations of this study include those related to any
retrospective analyses and to its relatively small sample
size. Complete medical records were not available for all
patients, which limited the available information on patho-
genic and echocardiographic findings. In addition, because
of the long study period, several different surgeons were
involved, and surgical techniques and antibiotic therapy
have evolved. However, indications for surgery remain es-
sentially unchanged, and the need for early surgical referral
for complicated endocarditis is reinforced by our findings of
low operative morbidity and mortality, which compare fa-
vorably with the results of other studies of medically man-
aged patients with complicated endocarditis.11
Surgical treatment of veterans with active endocarditis
can be accomplished safely, with low operative mortality
and morbidity. Early surgical referral is advisable. On the
basis of our data, relatively poor unadjusted long-term sur-
vival should be anticipated in the veteran population.
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